Your browser doesn't support javascript.
loading
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease.
Martínez-Romero, Gregorio J; Alvariño, Ana; Hinojosa, Esther; Mora, Maria; Oltra, Lorena; Maroto, Nuria; Ferrer, Isabel; Hinojosa, María Dolores; Hinojosa, Joaquin Ernesto.
Affiliation
  • Martínez-Romero GJ; Department of Pharmacy, Hospital de Manises.
  • Alvariño A; Laboratory Department,, Hospital de Manises.
  • Hinojosa E; IBD Unit,, Hospital de Manises.
  • Mora M; IBD Unit, Hospital de Manises.
  • Oltra L; IBD Unit, Hospital de Manises.
  • Maroto N; IBD Unit, Hospital de Manises.
  • Ferrer I; IBD Unit, Hospital de Manises.
  • Hinojosa MD; IBD Unit, Hospital de Manises.
  • Hinojosa JE; Servicio de Medicina Digestiva, Hospital de Manises, España.
Rev Esp Enferm Dig ; 111(6): 431-436, 2019 Jun.
Article in En | MEDLINE | ID: mdl-31021170

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Adalimumab / Anti-Inflammatory Agents / Models, Chemical Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Rev Esp Enferm Dig Journal subject: GASTROENTEROLOGIA Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Adalimumab / Anti-Inflammatory Agents / Models, Chemical Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Rev Esp Enferm Dig Journal subject: GASTROENTEROLOGIA Year: 2019 Type: Article